Glucocorticoid prevents CD138 expression in T cells of autoimmune MRL/lpr mice
CD138+ T cells, the majority of which are CD4 and CD8 double‑negative (DN) T cells, contribute to the production of anti‑dsDNA antibodies in a CD4 receptor‑dependent way to promote the development of systemic lupus erythematosus (SLE). Accumulation...
Main Authors: | Li, P. (Author), Liu, H. (Author), Xie, T. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Interleukin‑27 ameliorates allergic asthma by alleviating the lung Th2 inflammatory environment
by: Guo, Z., et al.
Published: (2022) -
Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01) -
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
by: Juan M. Mejía-Vilet, et al.
Published: (2021-02-01) -
Glucocorticoids in <i>Systemic Lupus Erythematosus</i>. Ten Questions and Some Issues
by: Sabrina Porta, et al.
Published: (2020-08-01) -
Metabolic Profiling Reveals an Abnormal Pattern of Serum Fatty Acids in MRL/lpr Mice Under Treatment With Prednisone
by: Qianqian Li, et al.
Published: (2020-02-01)